Supply of Haemophilia A Treatment Products to NHS National Services Scotland

Awarded Unknown

View live tenders

The Common Services Agency (NHS National Services Scotland) awarded a contract to Novo Nordisk Ltd, Shire Pharmaceuticals Limited, and Swedish Orphan Biovitrum Ltd for the supply of products for the treatment of Haemophilia A, with a contract value of GBP 4,100,000.

Similar open tenders12

Other similar contracts12

Supply of Haemophilia A Treatments to NHS National Services ScotlandHealth & MedicalOctapharma Ltd,Novo Nordisk Ltd,Pfizer Ltd,Shire Pharmaceuticals Limited
$22,813,000
Supply of Enhanced Half-Life Recombinant Factor VIII for Blood Disorders to NHS ScotlandHealth & MedicalNovo Nordisk Ltd,Swedish Orphan Biovitrum Ltd
$7,134,755
Supply of Blood Disorder Treatments Including Haemophilia A & B to NHS ScotlandHealth & MedicalTakeda UK Limited,Pfizer Limited
$4,604,830
Supply of Plasma-Derived Factor VIII for Haemophilia A Treatment to NHS National Services ScotlandHealth & MedicalGrifols UK Limited,Biotest (UK) Ltd,Octapharma Ltd,Bio Products Laboratory
$718,000
Supply of Recombinant Factor XIII for Blood Disorders to NHS ScotlandHealth & MedicalNovo Nordisk Ltd
$129,113
Supply of Recombinant Factor VII for Blood Disorders to NHS ScotlandHealth & MedicalNovo Nordisk Ltd,LFB Biopharmaceuticals Ltd
$604,584
Supply of Standard Half-Life Recombinant Factor VIII for Blood Disorders to NHS ScotlandHealth & MedicalTakeda UK Limited,Pfizer Limited,Octapharma Ltd
$9,070,137
Supply of Blood Disorder Treatments to NHS ScotlandHealth & MedicalOctapharma Ltd,CSL Behring
$532,441
Supply of Enhanced Half-Life Recombinant Factor VIII for Blood Disorders to NHS ScotlandHealth & MedicalRoche Products Ltd
$40,327,988
Supply of Blood Disorder Treatments Including Haemophilia A & B to NHS ScotlandHealth & MedicalTakeda UK Limited,Octapharma Ltd,CSL Behring
$1,380,752
Supply of Haemophilia A Treatment Products under NHS National Framework AgreementHealth & MedicalBio Products Laboratory Ltd,Biotest (UK) Ltd,Grifols UK Ltd,Novo Nordisk Ltd,Octapharma Ltd,Pfizer Ltd,Roche Products Ltd,Shire Pharmaceuticals Limited,Swedish Orphan Biovitrum Ltd (Sobi UK)
$334,400,000
Supply of Blood Disorder Treatment Products (Factor X) to NHS ScotlandHealth & MedicalBio Products Laboratory
$1

GovMarket

We do the hard work.
You win the work.

We find the tenders, read the documents and track who wins, so your time goes on bids you can win.

–open health and medical tenders right now
–new in the last 7 days
–contracts awarded in the last 12 months
7 days free, then £36/GBP per month

You're In — Free Trial Activated

You now have full access to GovMarket Premium for 7 days. You’ll be charged at the end of the trial unless you cancel.

  • Tell Us What You Do — We'll surface the tenders that are most relevant to your business.